Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
G. Vavougios, T. Kerenidi, I. Tsilioni, K. Gourgoulianis (Larissa, Greece). The protein DJ-1 in malignant pleural effusions due to lung cancer: Levels and correlations with oxidative stress biomarkers. Eur Respir J 2013; 42: Suppl. 57, 2914

Member's Comments

No comment yet.

Related content which might interest you: Elevated survivin is associated with a reduced survival in patients with malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Reactive oxygen species modulator 1 (Romo1) as a diagnostic marker for lung cancer-related malignant effusion Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Role of Dr-70 immunoassay in suspected malignant pleural effusion Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Serum osteopontin as a prognostic marker in patients with lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Activated KRAS signaling triggers malignant pleural effusion Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Serum and bronchial aspiration fluid HE-4 levels in lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Expression and clinical significance of S100 calcium binding protein A2 in lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Survival of non small cell lung carcinoma patients with malignant pleural effusions Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Predictive parameters of survival in malignant pleural effusion Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 The evaluation of biological and clinical significance of alpha-1 antitrypsin in non-small cell lung cancer Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Pleural eicosanoids in patients with lung cancer Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough? Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 LATE-BREAKING ABSTRACT: A proteomic study of benign and malignant pleural effusions Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Prevalence of molecular changes in resected pulmonary adenocarcinomas Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference? Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 MUC1 gene polymorphism and serum KL-6 in lung adenocarcinoma Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015